Universitätsklinikum Essen

METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII (2024) Kocak B, Akinci D’Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, Andreychenko AE, et al. Journal article Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer (2024) Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, et al. Journal article A multimodal aftercare intervention improves the outcome after kidney transplantation – results of the KTx360° aftercare program using claims data (2024) Pape L, DeZwaan M, Nöhre M, Klewitz F, Kyaw Tha Tun E, Prüfe J, Schiffer L, et al. Journal article Diagnosis and treatment of venous leg ulcers: S2k Guideline of the German Society of Phlebology and Lymphology (DGPL) e.V. (2024) Valesky EM, Hach-Wunderle V, Protz K, Zeiner KN, Erfurt-Berge C, Goedecke F, Jäger B, et al. Journal article Quality of life of short-statured children and adolescents and growth hormone treatment Lebensqualität von kleinwüchsigen Kindern und Jugendlichen und Wachstumshormontherapie (2024) Quitmann JH, Binder G, Witt S, Bullinger M, Blömeke J, Fricke-Otto S, Hauffa B, et al. Journal article Diagnostik und Therapie des Ulcus cruris venosum: S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie und Lymphologie (DGPL) e.V. (2024) Valesky EM, Hach-Wunderle V, Protz K, Zeiner KN, Erfurt-Berge C, Goedecke F, Jäger B, et al. Journal article Technical considerations for isolated limb perfusion: A consensus paper (2024) Hayes AJ, Coker DJ, Been L, Boecxstaens VW, Bonvalot S, De Cian F, de la Cruz-Merino L, et al. Journal article, Review article Osteosarcomas in retinoblastoma-survivors. A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS) (2024) Bielack SS, Baumhoer D, Hecker-Nolting S, Hettmer S, Kager L, Ketteler P, Kevric M, et al. Journal article Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer (2024) Weiten R, Niemann M, Below E, Friker LL, Ralser DJ, Toma M, Kristiansen G, et al. Journal article